focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerguson Regulatory News (FERG)

Share Price Information for Ferguson (FERG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16,610.00
Bid: 16,585.00
Ask: 16,600.00
Change: -420.00 (-2.47%)
Spread: 15.00 (0.09%)
Open: 16,720.00
High: 16,820.00
Low: 16,580.00
Prev. Close: 17,030.00
FERG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share repurchase program

19 Dec 2022 07:00

RNS Number : 0650K
Ferguson PLC
19 December 2022
 

December 19, 2022

FERGUSON PLC

Share repurchase program

Ferguson plc (the "Company") announces that, in continuation of its $2.5 billion share repurchase program (the "Program"), it has entered into an irrevocable and non-discretionary arrangement with its broker Barclays Capital Securities Limited and Barclays Capital Inc. (together, "Barclays") commencing from December 19, 2022 and ending no later than January 12, 2023. Under this arrangement, Barclays, an independent third party, will act as principal and will make decisions under the program independently from the Company.

The maximum pecuniary amount allocated to this tranche of the Program is £110 million. The value of shares repurchased by the Company under the Program pursuant to the various arrangements entered into with its brokers will not, in aggregate, exceed US$2,500 million.

The Company's shareholders generally authorized the Company to purchase up to a maximum of 20,845,062 of its ordinary shares at its Annual General Meeting held on November 30, 2022. Pursuant to such authority, the Company intends to continue purchasing shares under the Program. The aggregate number of shares acquired by the Company pursuant to the Program shall not exceed the maximum number of shares which the Company is authorized to purchase pursuant to such general authority. It is intended that any shares repurchased under the Program will be transferred into treasury.

The purpose of the Program is to reduce the capital of the Company. To the extent required, the Company may in future use the repurchased shares to satisfy share awards. Any purchases of shares by the Company in relation to this tranche of the Program will be carried out on the London Stock Exchange and/or the New York Stock Exchange (in accordance with the terms of the arrangement entered into with Barclays) and in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase shares granted by its shareholders, the Market Abuse Regulation 596/2014 (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018), Rule 10b5-1 and Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended.

For further information please contact

Ferguson plc

 Brian Lantz, Vice President IR and Communications

Mobile:

+1 224 285 2410

Pete Kennedy, Director of Investor Relations

Mobile:

+1 757 603 0111

 

Media Enquiries

 John Pappas, Director of Financial Communication

Mobile:

+1 484 790 2727

 

 

About Ferguson plc

Ferguson plc (NYSE: FERG; LSE: FERG) is a leading value-added distributor in North America providing expertise, solutions and products from infrastructure, plumbing and appliances to HVAC, fire, fabrication and more. We exist to make our customers' complex projects simple, successful and sustainable. Ferguson is headquartered in the U.K., with its operations and associates solely focused on North America and managed from Newport News, Virginia. For more information, please visit http://www.fergusonplc.com or follow us on LinkedIn https://www.linkedin.com/company/ferguson-enterprises.

Cautionary note regarding forward-looking statements

Certain information in this announcement is forward-looking within the meaning of the United States Private Securities Litigation Reform Act of 1995, including with relation to our share repurchase program and its purpose and timetable. Forward-looking statements cover all matters which are not historical facts and speak only as of the date on which they are made. Forward-looking statements can be identified by the use of forward-looking terminology such as "will," "intend," or other variations or comparable terminology. Many factors could cause actual results to differ materially from those in such forward-looking statements, including, but not limited to: risks associated with the relocation of our primary listing to the US and any volatility in our share price and shareholder base in connection therewith; weakness in the economy, market trends, uncertainty and other conditions in the markets in which we operate, and other factors beyond our control, including any macroeconomic or other consequences of the current conflict in Ukraine; failure to rapidly identify or effectively respond to direct and/or end customers' wants, expectations or trends, including costs and potential problems associated with new or upgraded information technology systems; adverse impacts caused by the COVID-19 pandemic (or related variants); unsuccessful execution of our operational strategies; and the risks and uncertainties set forth in our Form 10-K filed with the Securities and Exchange Commission ("SEC") on September 27, 2022, under the heading "Risk Factors," and in other documents we furnish to or file with the SEC in the future. Forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. Other than in accordance with our legal or regulatory obligations we undertake no obligation to update publicly or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRBDDCBBDGDL
Date   Source Headline
8th Oct 20217:00 amRNSTransaction in Own Shares
7th Oct 20217:00 amRNSTransaction in Own Shares
6th Oct 20217:00 amRNSTransaction in Own Shares
5th Oct 20217:00 amRNSTransaction in Own Shares
4th Oct 20217:00 amRNSDirector/PDMR Shareholding
4th Oct 20217:00 amRNSTransaction in Own Shares
1st Oct 20217:00 amRNSTotal Voting Rights
1st Oct 20217:00 amRNSTransaction in Own Shares
30th Sep 20217:00 amRNSShare buy back program
29th Sep 20217:00 amRNS2021 Annual Report on Form 20-F
28th Sep 20217:00 amRNSResults for the year ended July 31, 2021
14th Sep 202110:00 amRNSNotice of Results
1st Sep 20217:00 amRNSTotal Voting Rights
24th Aug 20218:00 amRNSDirector Declaration
2nd Aug 20217:00 amRNSTotal Voting Rights
29th Jul 20217:00 amRNSTransaction in Own Shares
28th Jul 20217:00 amRNSTransaction in Own Shares
26th Jul 20217:00 amRNSTransaction in Own Shares
22nd Jul 20217:00 amRNSTransaction in Own Shares
21st Jul 20217:00 amRNSTransaction in Own Shares
20th Jul 20217:00 amRNSTransaction in Own Shares
19th Jul 20217:00 amRNSTransaction in Own Shares
16th Jul 20217:00 amRNSTransaction in Own Shares
15th Jul 20217:00 amRNSTransaction in Own Shares
14th Jul 20217:00 amRNSTransaction in Own Shares
13th Jul 20217:00 amRNSTransaction in Own Shares
9th Jul 20217:00 amRNSTransaction in Own Shares
8th Jul 20217:00 amRNSTransaction in Own Shares
7th Jul 20217:00 amRNSTransaction in Own Shares
6th Jul 20217:00 amRNSTransaction in Own Shares
5th Jul 20217:00 amRNSTransaction in Own Shares
2nd Jul 20217:00 amRNSTransaction in Own Shares
1st Jul 20217:00 amRNSTotal Voting Rights
1st Jul 20217:00 amRNSTransaction in Own Shares
30th Jun 20217:00 amRNSTransaction in Own Shares
29th Jun 20219:00 amRNSIFRS to US GAAP Investor Session
29th Jun 20217:00 amRNSTransaction in Own Shares
28th Jun 20217:00 amRNSTransaction in Own Shares
24th Jun 20217:00 amRNSTransaction in Own Shares
23rd Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
21st Jun 20217:00 amRNSTransaction in Own Shares
18th Jun 20217:00 amRNSDirector/PDMR Shareholding
18th Jun 20217:00 amRNSTransaction in Own Shares
17th Jun 20217:00 amRNSTransaction in Own Shares
16th Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSTransaction in Own Shares
14th Jun 20217:00 amRNSShare buy back program
14th Jun 20217:00 amRNSTransaction in Own Shares
11th Jun 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.